TRACY GARRETT-REED: Open Payments
NPI 1760744783 · BAYTOWN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 15 payments from 13 companies in 2025. Trend: 2023 $2,014 · 2024 $1,892 · 2025 $616
Food & beverage: $522Education: $94
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $142 |
| Gilead Sciences, Inc. | 1 | $121 |
| Regeneron Healthcare Solutions, Inc. | 1 | $83 |
| AstraZeneca Pharmaceuticals LP | 1 | $49 |
| Secura Bio, Inc. | 1 | $43 |
| Rigel Pharmaceuticals, Inc. | 1 | $30 |
| Pharmacosmos Therapeutics Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $23 |
| PFIZER INC. | 1 | $23 |
| Eisai Inc. | 1 | $22 |
Products named: Trodelvy, LIBTAYO, COPIKTRA, TAVALISSE, MONOFERRIC, MONJUVI, PEMAZYRE, Enhertu.
Industry payments across TX — which companies pay providers there.
